The publication of modern slavery statements (statements) on this Register does not indicate compliance with the requirements of the Modern Slavery Act 2018 (the Act). Pursuant to section 19(2) of the Act, the Attorney-General’s Department publishes all statements properly submitted to this Register, including compliant and non-compliant statements, in order to maximise transparency and ensure entities are publicly accountable for their actions to address modern slavery risks. Statements that fail to meet the requirements for approval and signature set out in sections 13(2) or 14(2) of the Act will not be registered.

Number
2021-2377
Type
Joint
Title
AstraZeneca Holdings Pty Limited and AstraZeneca Pty Limited
Period
01 January 2020 to 31 December 2020
Annual revenue
1BN+
Industry sectors
Healthcare and pharmaceuticals
Countries
Australia
Key brands and business names
AstraZeneca Pty Limited, Symbicort, Zoladex, Brilinta, Nexium, Tagrisso, Imfinzi, Forxiga
Date submitted
30/06/2021
Date published
09/07/2021